Most Read Articles
Tristan Manalac, 11 Jul 2018
Gestational exposure to grain products fortified with folic acid appears to be linked to a lower risk of psychosis in offspring, according to a recent study.
Pearl Toh, 10 Jul 2018
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
4 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 5 days ago
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.

Psoriatic patients underdiagnosed, undertreated for hypertension and dyslipidaemia

08 Mar 2018

There appear to be several patients with psoriasis and psoriatic arthritis (PsA) who are underdiagnosed and undertreated for hypertension and dyslipidaemia in actual situations, a recent study has found.

Overall, 2,254 patients (58.9 percent PsA; 41.1 percent psoriasis; mean age 52 years; 53 percent men) from eight centres in Canada, Israel and the United States were included in this study.

Of the participants, 87.6 percent had at least one modifiable cardiovascular risk factor (CVRF), 45.1 percent had hypertension, 49.4 percent dyslipidaemia, 13.3 percent diabetes, 75.3 percent were overweight or obese, 54.3 percent had central obesity, and 17.3 percent were current smokers.

There were 59.2 percent and 65.6 percent of patients with hypertension and dyslipidaemia, respectively, who were undertreated. Moreover, undertreatment correlated with younger age (≤50 years), having psoriasis and male sex.

To estimate the number of underdiagnosis and undertreatment of CVRF in an international multicentre cohort of patients with psoriasis and PsA, researchers conducted a cross-sectional of patients with psoriatic disease form the International Psoriasis and Arthritis Research Team cohort. They determined the presence of modifiable CVRF (diabetes, hypertension, dyslipidaemia, smoking, elevated body mass index and central obesity) and the use of appropriate therapies for hypertension and dyslipidaemia.

The Framingham Risk Score was used to calculate the 10-year CV risk. Physician adherence with guidelines for the treatment of hypertension and dyslipidaemia was also evaluated. Finally, researchers used regression analysis to assess predictors of undertreatment of hypertension and dyslipidaemia.

“Strategies to improve the management of CVRF in psoriatic patients are warranted,” according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 11 Jul 2018
Gestational exposure to grain products fortified with folic acid appears to be linked to a lower risk of psychosis in offspring, according to a recent study.
Pearl Toh, 10 Jul 2018
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
4 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 5 days ago
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.